Over the past two decades, researchers have been evaluating alpha-synuclein in the gastrointestinal tract of PD patients during manifest and prodromal phases, as noted by Liu et al. However, the findings have been contradictory. The gene discussed is SNCA; the disease is Parkinson disease.